VV

Venkata Varaha Alekhya Burli

Active Director Director DIN 10858476
DIN 10858476 First appointment Dec 2024
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Venkata Varaha Alekhya Burli

Data last updated:

Venkata Varaha Alekhya Burli is a Director at Eliza Pharma Private Limited (since 2024).

DIN 10858476
Primary Designation Director
First Appointment 02 Dec 2024
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Eliza Pharma Private Limited U46497TS2024PTC191624
Director02 Dec 20242024Active

Board colleagues of Venkata Varaha Alekhya Burli

NameDINCompanyDesignation
Gopi Thota10858475Eliza Pharma Private LimitedDirector
Prapurna Battu Vani10858474Eliza Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Eliza Pharma Private Limited
Premium access

Shareholding and investment profile for Venkata Varaha Alekhya Burli

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Venkata Varaha Alekhya Burli

Venkata Varaha Alekhya Burli currently holds 1 directorship: Eliza Pharma Private Limited (Director, since 02 Dec 2024).

Venkata Varaha Alekhya Burli was first appointed on 02 Dec 2024 as Director at Eliza Pharma Private Limited.

The current boards of Venkata Varaha Alekhya Burli's companies include Gopi Thota (Eliza Pharma Private Limited), Prapurna Battu Vani (Eliza Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available